Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains

  1. Timothy D. Spector3,6
  1. 1 Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, United Kingdom;
  2. 2 The Gurdon Institute and Department of Genetics, University of Cambridge, Cambridge CB2 1QN, United Kingdom;
  3. 3 Department of Twin Research and Genetic Epidemiology, King's College London, St. Thomas' Hospital Campus, London SE1 7EH, United Kingdom;
  4. 4 The Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom
    1. 5 These authors contributed equally to this work.

    2. 6 These authors contributed equally to this work.

    Abstract

    There is a growing realization that some aging-associated phenotypes/diseases have an epigenetic basis. Here, we report the first genome-scale study of epigenomic dynamics during normal human aging. We identify aging-associated differentially methylated regions (aDMRs) in whole blood in a discovery cohort, and then replicate these aDMRs in sorted CD4+ T-cells and CD14+ monocytes in an independent cohort, suggesting that aDMRs occur in precursor haematopoietic cells. Further replication of the aDMRs in buccal cells, representing a tissue that originates from a different germ layer compared with blood, demonstrates that the aDMR signature is a multitissue phenomenon. Moreover, we demonstrate that aging-associated DNA hypermethylation occurs predominantly at bivalent chromatin domain promoters. This same category of promoters, associated with key developmental genes, is frequently hypermethylated in cancers and in vitro cell culture, pointing to a novel mechanistic link between aberrant hypermethylation in cancer, aging, and cell culture.

    Footnotes

    Related Articles

    | Table of Contents

    Preprint Server